Emerging Therapy Solutions® (ETS) helps reinsurance and stop-loss payers, health plans and self-funded employers manage the risks associated with high-cost therapies for rare and complex conditions. We offer a suite of End-to-End Solutions for cell and gene therapies, solid organ and bone marrow transplants, and other highly specialized therapies.